全文获取类型
收费全文 | 362篇 |
免费 | 4篇 |
专业分类
儿科学 | 13篇 |
妇产科学 | 2篇 |
基础医学 | 9篇 |
口腔科学 | 8篇 |
临床医学 | 62篇 |
内科学 | 196篇 |
皮肤病学 | 3篇 |
神经病学 | 18篇 |
特种医学 | 7篇 |
外科学 | 23篇 |
综合类 | 7篇 |
预防医学 | 9篇 |
眼科学 | 1篇 |
药学 | 5篇 |
中国医学 | 2篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 5篇 |
2022年 | 4篇 |
2021年 | 12篇 |
2020年 | 6篇 |
2019年 | 38篇 |
2018年 | 52篇 |
2017年 | 16篇 |
2016年 | 6篇 |
2015年 | 6篇 |
2014年 | 53篇 |
2013年 | 32篇 |
2012年 | 13篇 |
2011年 | 32篇 |
2010年 | 23篇 |
2009年 | 5篇 |
2008年 | 16篇 |
2007年 | 16篇 |
2006年 | 7篇 |
2005年 | 5篇 |
2004年 | 2篇 |
2003年 | 3篇 |
2002年 | 1篇 |
2000年 | 4篇 |
1998年 | 3篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 2篇 |
排序方式: 共有366条查询结果,搜索用时 15 毫秒
1.
2.
《Heart rhythm》2019,16(8):e66-e93
3.
4.
Paul K. Whelton Robert M. Carey Wilbert S. Aronow Donald E. Casey Karen J. Collins Cheryl Dennison Himmelfarb Sondra M. DePalma Samuel Gidding Kenneth A. Jamerson Daniel W. Jones Eric J. MacLaughlin Paul Muntner Bruce Ovbiagele Sidney C. Smith Crystal C. Spencer Randall S. Stafford Sandra J. Taler Randal J. Thomas Jackson T. Wright 《Journal of the American College of Cardiology》2018,71(19):e127-e248
5.
Coronary heart disease (CHD) is one of the leading causes of morbidity and the most common cause of death in older adults. Paradoxically, elderly patients tend to be systematically excluded from randomized-controlled cardiovascular trials, which complicates decision-making in this population. Management of CHD in the elderly is frequently more difficult in virtue of chronic comorbid conditions and aging-intrinsic dynamics. Despite these challenges, the number of elderly and very elderly patients undergoing percutaneous coronary interventions (PCI) is increasing. Elderly patients in many registries and large clinical series exhibit even a greater benefit from interventional procedures than younger patients, but they have a higher rate of overall complications. We present an overview of the current available evidence of PCI in older adults with stable and unstable CHD, including comparisons between drug-eluting and bare-metal stents, transfemoral and transradial access, and methods of revascularization. Adjuvant antiplatelet and antithrombotic therapies are also discussed. 相似文献
6.
《Journal of the American College of Cardiology》2011,58(24):2550-2583
7.
Anjan Tibrewala Arif Jivan William J. Oetgen Neil J. Stone 《Journal of the American College of Cardiology》2018,71(7):794-799
Lipid treatment guidelines have continued to evolve as new evidence emerges. We sought to review similarities and differences of 5 lipid treatment guidelines from the American College of Cardiology/American Heart Association, Canadian Cardiovascular Society, European Society for Cardiology/European Atherosclerosis Society, U.S. Preventive Services Task Force, and U.S. Veterans Affairs/Department of Defense. All guidelines utilize rigorous evidentiary review, highlight statin therapy for primary and secondary prevention of atherosclerotic cardiovascular disease, and emphasize a clinician-patient risk discussion. However, there are differences in statin intensities, use of risk estimators, treatment of specific patient subgroups, and consideration of safety concerns. Clinicians should understand these similarities and differences in current and future guideline recommendations when considering if and how to treat their patients with statin therapy. 相似文献
8.
《Indian heart journal》2021,73(4):481-486
IntroductionIn 2017, the American College of Cardiology/American Heart Association revised guidelines for diagnosis and management of hypertension in adults. The regional impact of the updated guidelines on the prevalence of hypertension in India is unknown.MethodsData from nationally representative Indian households were analyzed to estimate the regional prevalence of hypertension according to the old and the new guidelines in men (age 18–54 years) and women (age 18–49 years). The old guidelines defined hypertension as a systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg or treatment. The new guidelines define hypertension as a systolic blood pressure of ≥130 mmHg or diastolic blood pressure of ≥80 mmHg or treatment. We calculated the increase in the prevalence of hypertension among the states and union territories of India (hereafter “states”).ResultsAmong 679,712 participants (85.6% women), the median age was 31 years (interquartile range 24, 40) and was comparable among men and women (33 vs. 31 years, respectively). The overall weighted prevalence according to old and new guidelines was 18.5% (95% CI 18.2, 18.7) and 43.0% (95% CI 42.8, 43.3), respectively. There was a significant increase in hypertension prevalence, both among men and women, and across all regions. The northeast region of the country had the highest prevalence.ConclusionThe overall prevalence of hypertension significantly increases with the new compared to the old guidelines, however, the regional heterogeneity of prevalence of hypertension is maintained. 相似文献
9.
Amrit Kanwar Jeremy J. Thaden Vuyisile T. Nkomo 《Mayo Clinic proceedings. Mayo Clinic》2018,93(4):488-508
With increased life expectancy and aging of the population, aortic stenosis is now one of the most common valvular heart diseases. Early recognition and management of aortic stenosis are of paramount importance because untreated symptomatic severe disease is universally fatal. The advent of transcather aortic valve replacement technologies provides exciting avenues of care to patients with this disease in whom traditional surgical procedures could not be performed or were associated with high risk. This review for clinicians offers an overview of aortic stenosis and updated information on the current status of various treatment strategies. An electronic literature search of PubMed, MEDLINE, EMBASE, and Scopus was performed from conception July 1, 2016, through November 30, 2017, using the terms aortic stenosis, aortic valve replacement, transcatheter aortic valve replacement (TAVR), transcatheter aortic valve insertion (TAVI), surgical aortic valve replacement, aortic stenosis flow-gradient patterns, low-flow aortic valve stenosis, natural history, stress testing, pathophysiology, bicuspid aortic valve, and congenital aortic valve disease. 相似文献
10.
ObjectivesThis study aims to compare the 2017-ACC/AHA hypertension guideline with 2014-JNC-8 guideline in regard to the number of patients who are eligible for treatment and to determine the physicians’ adherence and the financial impact of implementing the new guideline.MethodsA cross-sectional observational study was conducted on adult patients who attended the hospital outpatient setting in UAE during January 1, 2018 till February 28, 2018. Adults who are diagnosed with hypertension and those with blood pressure (BP) levels based on two or more readings obtained on two or more different occasions were screened for inclusion into this study and cardiovascular diseases (CVD) risk was calculated. The two guidelines were compared with respect to the number of patients diagnosed with hypertension and eligible for treatment. Results were extrapolated to the UAE population. Financial impact of applying the 2017-ACC/AHA guideline was also evaluated.ResultsIn comparison with the JNC-8, the 2017-ACC/AHA guideline would increase the proportion of patients diagnosed with hypertension among UAE adults from 40.8% to 76.3% and the number of UAE adults recommended for antihypertensive medications would rise from 2.42 million (32.1%) to 4.71 million (62.5%). Among UAE adults, almost 4.42 million (58.6%) and 0.76 million (10.1%) would have BP above the target according to the 2017-ACC/AHA and JNC-8 guidelines, respectively. The expected increase in the cost of anti-hypertension medications prescribed for the new labeled cases according to 2017-ACC/AHA but not JNC-8 would reach 1.8 billion AED/year. For those who were recommended for antihypertensive medications, who had BP above target, the additional cost would reach 3.5 billion AED/year.ConclusionsThe current study reveals marked increase in the proportion of patients diagnosed with hypertension in concordance with the 2017-ACC/AHA guideline. This is also will be associated with almost double the number of UAE adults recommended for antihypertensive medications. The poor compliance with the 2017-ACC/AHA reflects the concern regarding the increase risk of adverse events. 相似文献